- Home
- UBFO vs ALEC Comparison
UBFO vs ALEC Comparison
Compare UBFO & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBFO | ALEC |
|---|---|---|
| Founded | 1987 | 2013 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 192.9M | 204.1M |
| IPO Year | 2001 | 2019 |
Fundamental Metrics
Financial Performance| Metric | UBFO | ALEC |
|---|---|---|
| Price | $10.93 | $1.98 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $3.33 |
| AVG Volume (30 Days) | 25.7K | ★ 773.4K |
| Earning Date | 04-23-2026 | 01-01-0001 |
| Dividend Yield | ★ 4.37% | N/A |
| EPS Growth | N/A | ★ 21.15 |
| EPS | ★ 0.51 | N/A |
| Revenue | $2,918,000.00 | ★ $100,600,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $21.33 | ★ N/A |
| Revenue Growth | N/A | ★ 3.60 |
| 52 Week Low | $7.32 | $0.87 |
| 52 Week High | $11.52 | $3.40 |
Technical Indicators
Market Signals| Indicator | UBFO | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 53.82 | 59.92 |
| Support Level | $10.84 | $1.84 |
| Resistance Level | $11.19 | $2.03 |
| Average True Range (ATR) | 0.26 | 0.12 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 42.86 | 75.41 |
Price Performance
Historical ComparisonAbout UBFO United Security Bancshares
United Security Bancshares operates as the holding for United Security Bank. It provides commercial banking services to the business and professional community, and individuals located in Fresno, Madera, Santa Clara, and Kern Counties. It offers checking and savings accounts, deposits, mortgage loans, credit and debit cards, safe deposit boxes, automated teller machines, wire transfers, money market accounts, mobile banking, and wealth management services. The company's primary sources of revenue are interest income from loans and investment securities.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.